SEC Form 4 · accession 0001179110-18-006429
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon J Bracken
Officer — Senior Vice President
Period of report
May 4, 2018
Accepted (ET)
May 8, 2018 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | May 4, 2018 | S | 300 | $58.56 | D | 43,990 | D | |
| Common shares without par value | May 4, 2018 | S | 400 | $58.5601 | D | 43,590 | D | |
| Common shares without par value | May 4, 2018 | S | 450 | $58.561 | D | 43,140 | D | |
| Common shares without par value | May 4, 2018 | S | 1,000 | $58.565 | D | 42,140 | D | |
| Common shares without par valueF1 | holding | — | — | — | 747 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of May 8, 2018.